Literature DB >> 15965487

BRCA1 participates in DNA decatenation.

Zhenkun Lou1, Katherine Minter-Dykhouse, Junjie Chen.   

Abstract

The tumor suppressor BRCA1 has an important function in the maintenance of genomic stability. Increasing evidence suggests that BRCA1 regulates cell cycle checkpoints and DNA repair after DNA damage. However, little is known about its normal function in the absence of DNA damage. Here we show that BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells. Similar to cells treated with the topoisomerase IIalpha inhibitor ICRF-193, BRCA1-deficient cells show lagging chromosomes, indicating a defect in DNA decatenation and chromosome segregation. More directly, BRCA1 deficiency results in defective DNA decatenation in vitro. Finally, topoisomerase IIalpha is ubiquitinated in a BRCA1-dependent manner, and topoisomerase IIalpha ubiquitination correlates with higher DNA decatenation activity. Together these results suggest an important role of BRCA1 in DNA decatenation and reveal a previously unknown function of BRCA1 in the maintenance of genomic stability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965487     DOI: 10.1038/nsmb953

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  56 in total

1.  Mammalian Fbh1 is important to restore normal mitotic progression following decatenation stress.

Authors:  Corentin Laulier; Anita Cheng; Nick Huang; Jeremy M Stark
Journal:  DNA Repair (Amst)       Date:  2010-04-24

2.  Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.

Authors:  Da Yang; Sofia Khan; Yan Sun; Kenneth Hess; Ilya Shmulevich; Anil K Sood; Wei Zhang
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

Review 3.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

4.  BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation.

Authors:  Brian P Chadwick; Timothy F Lane
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

5.  Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II.

Authors:  Chung-Pei Lee; Jen-Yang Chen; Jiin-Tarng Wang; Keiji Kimura; Ai Takemoto; Chih-Chung Lu; Mei-Ru Chen
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

Review 6.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

7.  Discovery of cellular regulation by protein degradation.

Authors:  Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

Review 8.  Maintaining genome stability at the replication fork.

Authors:  Dana Branzei; Marco Foiani
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

9.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

10.  The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.

Authors:  Iris Alchanati; Carmit Teicher; Galit Cohen; Vivian Shemesh; Haim M Barr; Philippe Nakache; Danny Ben-Avraham; Anna Idelevich; Itzchak Angel; Nurit Livnah; Shmuel Tuvia; Yuval Reiss; Daniel Taglicht; Omri Erez
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.